PRINCETON, N.J., July 22, 2013 /PRNewswire/ -- Next Inning Technology Research (http://www.nextinning.com), an online investment newsletter focused on technology stocks, has issued updated outlooks for Apple (Nasdaq: AAPL), Sanmina (Nasdaq: SANM), Texas Instruments (Nasdaq: TXN), STMicroelectronics (NYSE: STM) and Altera (Nasdaq: ALTR).
Over the past decade, well over a thousand Wall Street analysts, money managers and institutional investors have joined thousands of savvy private investors in gaining key tech industry insights and intelligence from industry veteran and celebrated investor Paul McWilliams in his role as editor of Next Inning Technology Research.
"I value your research more than any others I read," said one hedge fund manager of Next Inning, recently. And a long-time tech industry analyst for a Wall Street research firm said, "I believe your research and calls are the best I have ever seen in my career." With McWilliams' impressive track record and unparalleled industry access, NI Technology Research has become an essential tool for analysts and investors looking to navigate today's complex technology landscape.
McWilliams' new installment of his acclaimed State of Tech series of reports covers 71 technology stocks and dives deep into a number of exciting, emerging tech trends, well ahead of the Wall Street curve. Trial subscribers will receive the 167-page report, which includes 35 detailed tables and graphs, for free, no strings attached. This report is a must read for investors and analysts focusing on technology in 2013.
To get ahead of the Wall Street curve and receive Next Inning's Q2 2013 State of Tech report, as well as McWilliams' upcoming Q2 2013 earnings preview, you are invited to take a free, 21-day, no obligation trial with Next Inning. For full details on this offer, please visit the following link:
Topics discussed in the latest reports include:
-- Apple: Next Inning is known for helping its readers generate strong returns, and no one has been more accurate than McWilliams when it comes to Apple. Nearly a decade ago, McWilliams advised readers that Apple was positioned to win big when it was trading for less than $10 per share (split adjusted). While many analysts turned negative on Apple when Steve Jobs died, McWilliams maintained his strongly bullish opinion. However, as Apple was hitting record highs in 2012, he advised Next Inning readers to sell. McWilliams again advised investors to sell Apple following its Q1 2013 earnings report. The stock opened the next day at $460. Apple fell to close Q2 below $400, but has recovered modestly in anticipation of its earnings report this week. Is now the time to invest in Apple, or should investors continue to avoid the stock ahead of its upcoming earnings report? What specifically does McWilliams say Apple should do to reclaim its former glory?
-- Sanmina: In his Q3 2012 State of Tech report, McWilliams outlined a compelling bullish thesis for Sanmina, but warned readers the price would likely dip before moving higher. Following that, the price of Sanmina fell 11% to a low of $7.58, but quickly rebounded to close the year at $11.07, where McWilliams reiterated his bullish outlook. What was Wall Street overlooking in the Sanmina equation? With the price now up roughly 100% from the Q4 2012 low, is the bullish view McWilliams outlined fully priced into the stock or does he see more upside potential during the next six to 12 months? Could shares hit the $20 mark? What is McWilliams' exit strategy?
-- Texas Instruments: TI has recently repositioned itself as an embedded processor solutions company. In what ways does this new direction put TI in the center of a new growth paradigm centered on the emergence of what is known as the "Internet of Things?" What two factors are driving this new paradigm? At what price would McWilliams add shares of TI? What TI competitors are most threatened by TI's new strategy?
-- STMicro: What company-specific factors have weighed on STMicro and why is Wall Street now showing interest in the stock? Does McWilliams see other factors shifting over time to work in the company's favor? In what critical growth market has STMicro recently overtaken Texas Instruments to be ranked number one by market share? Does STMicro offer investors long-term profit potential?
-- Altera: As we prepared to enter 2012, McWilliams forecasted Xilinx would outperform Altera for the next two years. Because Altera had been the big winner during 2010 and 2011, this was a bold prediction that went against the grain of Wall Street forecasts. However, McWilliams was right – Xilinx was the winner hands down in all categories. For the full year of 2012, the price of Xilinx went up 14.3% while the price of Altera went down 6.3%, and this year Xilinx is beating Altera by almost a 10 to 1 ratio. Does McWilliams continue to view Xilinx as a more attractive investment than its rival Altera? What key trends in the programmable logic sector are important to Xilinx and Altera investors and how does McWilliams see these trends shaping up for the rest of 2013?
Founded in September 2002, Next Inning's model portfolio has returned 290% since its inception versus 86% for the S&P 500.
About Next Inning:
Next Inning is a subscription-based investment newsletter that provides regular coverage on more than 150 technology and semiconductor stocks. Subscribers receive intra-day analysis, commentary and recommendations, as well as access to monthly semiconductor sales analysis, regular Special Reports, and the Next Inning model portfolio. Editor Paul McWilliams is a 30+ year semiconductor industry veteran.
NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
CONTACT: Marcia Martin, Next Inning Technology Research, +1-888-278-5515
SOURCE Indie Research Advisors, LLC